New Key Statistics Module, Z-Score and F-Score
OTCPK:NOXOF Key Ratios
Market Cap $ M | 13.84 |
Enterprise Value $ M | 6.32 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.05 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.03 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.70 |
EV-to-EBITDA | -0.70 |
PEG | -- |
Shares Outstanding M | 292.24 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 12.79 |
Current Ratio | 12.79 |
ROA % (ttm) | -92.81 |
ROE % (ttm) | -105.92 |
ROIC % (ttm) | -204.85 |
Dividend Yield % | -- |
Altman Z-Score | -- |
NOXOF Number of Guru Trades
NOXOF Volume of Guru Trades
Gurus Latest Trades with OTCPK:NOXOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:NOXOF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Noxopharm Ltd Insider Transactions
No Available Data
News about OTCPK:NOXOF
Total 0- 1